Ad is loading...
JCVVX
Price
$37.35
Change
-$0.15 (-0.40%)
Updated
Nov 15 closing price
VIVAX
Price
$68.72
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

JCVVX vs VIVAX

Header iconJCVVX vs VIVAX Comparison
Open Charts JCVVX vs VIVAXBanner chart's image
JHancock Classic Value R5
Price$37.35
Change-$0.15 (-0.40%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.72
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
JCVVX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JCVVX vs. VIVAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCVVX is a Buy and VIVAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. JCVVX (1.26B). VIVAX pays higher dividends than JCVVX: VIVAX (2.25) vs JCVVX (1.49). JCVVX was incepted earlier than VIVAX: JCVVX (16 years) vs VIVAX (32 years). JCVVX is a more actively managed with annual turnover of: 24.00 vs. VIVAX (10.00). JCVVX has a lower initial minimum investment than VIVAX: JCVVX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 25.55 vs. JCVVX (12.55). VIVAX return over 5 years is better than : 50.81 vs. JCVVX (19.26).
JCVVXVIVAXJCVVX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years32 years-
Gain YTD7.35817.91241%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.26B184B1%
Annual Yield % from dividends1.492.2566%
Returns for 1 year12.5525.5549%
Returns for 3 years-5.9821.58-28%
Returns for 5 years19.2650.8138%
Returns for 10 years56.85110.4651%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOST40.600.24
+0.59%
Toast
OUT17.90-0.04
-0.22%
OUTFRONT Media
FLWS7.80-0.09
-1.14%
1-800-FLOWERS.COM
SGMT4.73-0.45
-8.69%
Sagimet Biosciences
UPC0.14-0.02
-13.20%
Universe Pharmaceuticals